| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-05 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.002 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |